EFFICACY OF CANAKINUMAB, ON A REDUCED DOSE OR A PROLONGED DOSE INTERVAL WITHOUT CONCOMITANT CORTICOSTEROIDS AND METHOTREXATE, IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS

Pierre Quartier, Ekaterina Alexeeva, Carine Wouters, Inmaculada Calvo, Tilmann Kallinich, Nico Wulffraat, Xiaoling Wei, Alan Slade, Ken Abrams, Alberto Martini

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)98-99
JournalAnnals of the Rheumatic Diseases
Volume78
DOIs
Publication statusPublished - Jun 2019

Cite this